Search

Search Constraints

You searched for: Author/Creator Burris, Howard A.

Search Results

1. A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer. (March 2016)

2. A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer. (March 2016)

3. A Phase 2 Study of the Hsp90 Inhibitor AUY922 as Treatment for Patients with Refractory Gastrointestinal Stromal Tumors. (2nd July 2016)

4. A Randomized, Double‐Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX‐427) in Patients with Previously Untreated Stage IV Non‐Squamous‐Non‐Small‐Cell Lung Cancer: The SPRUCE Trial. (16th August 2019)

5. American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care. Issue 2 (10th January 2021)

6. Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium. (March 2018)

7. Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer. Issue 10 (1st April 2021)

9. Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non–small cell lung cancer: A randomized, placebo‐controlled phase 2 trial with correlated serum proteomic signatures. Issue 11 (12th April 2018)